Pharma needs to rethink pricing: Novartis CEO

Novartis CEO on ESG: Pandemic has been a reset for pharma's reputation

Diseases | Novartis

Careers in Research

Career Programs

Novartis generated $40 billion in innovative medicine sales, says CEO

Novartis CEO discusses developing a new Covid-19 treatment

Novartis CEO: It will take over a year to find vaccine for coronavirus